When you're putting a pharmaceutical agent into your body through a telehealth platform, the differences between providers matter. We evaluate them so you can choose with confidence.
The telehealth landscape has expanded rapidly — particularly in weight management, hormone therapy, and mental health. That expansion has created genuine access improvements for millions of patients. It has also created a quality variance problem: some platforms deliver rigorous clinical oversight with licensed providers, transparent pharmacy sourcing, and structured follow-up. Others function as medication dispensers with minimal screening and limited accountability.
TutelaMedical's Telehealth Evaluations apply a consistent five-criteria framework to every platform we assess. We're looking for the providers who treat telehealth as medicine — not as e-commerce with a prescription step.
Our Five-Criteria Evaluation Framework
1. Provider Credentials & Clinical Oversight
Are the prescribing providers licensed in the patient's state? What are their clinical credentials — MD, DO, NP, PA? Is there a supervising physician for mid-level providers? Most importantly: is there structured clinical follow-up after the initial prescription, or does the platform's engagement effectively end once medication ships? A legitimate medical service provides ongoing oversight. A medication dispenser provides a one-time transaction.
2. Medication Quality & Pharmacy Sourcing
This is where the most consequential differences exist, particularly in compounded GLP-1 programs. We evaluate: Does the dispensing pharmacy hold appropriate state licenses? Is it FDA-registered? Does it carry LegitScript certification or equivalent third-party verification? Is the distinction between compounded and FDA-approved brand-name medications clearly disclosed to the patient before purchase? When a platform ships compounded semaglutide, patients need to understand what that means — and how it differs from brand-name Wegovy or Ozempic — before they commit.
3. Total Cost Transparency
What is the actual all-in monthly cost? We break down: consultation or evaluation fees, monthly platform or membership fees, medication cost (and whether it increases at higher doses), supplies (syringes, alcohol swabs, sharps containers), shipping, and any charges for follow-up visits beyond the initial consultation. Platforms that advertise a low starting price but layer on additional costs at higher doses or for follow-up visits get flagged. You deserve to know the real number before you start.
4. Treatment Flexibility
Can your treatment be adjusted based on your response? Can you pause or discontinue without financial penalties or cancellation friction? Is dose titration managed by a provider reviewing your progress, or dictated by a fixed protocol regardless of individual response? Flexibility matters because weight management is not a one-size-fits-all process — your body's response at month three may require a different approach than month one.
5. Ongoing Patient Support
After the initial consultation, can you reach a licensed provider for questions about side effects, dose adjustments, or treatment concerns? Is there a defined response timeline, or does your message go into a queue with no service-level commitment? The first few weeks of GLP-1 therapy often involve side effect management that benefits from clinical guidance — platforms that disappear after prescribing leave patients navigating that alone.
Red Flags We Watch For
Before we recommend any telehealth platform, we screen for warning signs that indicate a service isn't operating with adequate clinical standards:
Guaranteed approval before evaluation. No legitimate medical service can promise you'll qualify for a prescription before reviewing your health information. GLP-1 medications have real contraindications. Any platform that approves everyone isn't performing adequate screening.
No provider identification. If you can't find out who is prescribing your medication — their name, credentials, and licensing state — that's a problem. You have the right to know who your prescribing provider is.
Undisclosed pharmacy sourcing. If the platform won't tell you which pharmacy compounds and dispenses your medication, or if that pharmacy can't be independently verified through state licensing databases, proceed with extreme caution.
No follow-up protocol. A single consultation followed by auto-shipping medication with no structured check-ins is not a medical program — it's a subscription box with a prescription attached.
Pressure-based enrollment. Limited-time pricing, countdown timers, “spots filling up” language — these are retail sales tactics, not indicators of a medical service operating in your clinical interest.
Latest Telehealth Evaluations
[This section will automatically populate with the most recent Telehealth Evaluation articles. If using a WordPress category archive, the theme will display posts assigned to the “Telehealth Evaluations” category below this content.]
Evaluations by Service Type
GLP-1 Weight Loss Programs — Semaglutide and tirzepatide telehealth platforms, including both brand-name and compounded medication programs. We evaluate clinical oversight, pharmacy sourcing, and true all-in costs.
Hormone Therapy & TRT — Testosterone replacement therapy and hormone optimization platforms. We assess provider qualifications, lab work protocols, and ongoing monitoring standards.
Mental Health & ADHD — Telehealth platforms offering psychiatric evaluation, medication management, and therapy services. We evaluate prescribing practices, follow-up protocols, and the clinical rigor of the assessment process.